Lipid profile of patients with acute myocardial infarction and its correlation with systemic inflammation

Biomarker Insights

Volumn 8, Issue , 2013, Pages

  Khan, Haseeb A ^a   Alhomida, Abdullah S ^a   Sobki, Samia H ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

Acute myocardial infarction; Biomarker; Inflammation; Lipid profile

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84873183259     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S11015     Document Type: Article

References (33)

1. Kumar A, Nagtilak S, Sivakanesan R, Gunasekera S. Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients a case controlled study from India. Southeast Asian J Trop Med Public Health. 2009;40:581- 592.
2. Kulsoom B, Nazrul SH. Association of serum Creactive protein and LDL:HDL with myocardial infarction. J Pak Med Assoc. 2006;56:318-322.
3. Karthikeyan G, Teo KK, Islam S, et al. Lipid Profile, plasma apolipopro teins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol. 2009;53:244-253.
4. Tokuda Y. Risk factors for acute myocardial infarction among Okinawans. J Nutr Health Aging. 2005;9:272-276.
5. Woo J, Ho SC, Wong SL, et al. Lipids, lipoproteins and other coronary risk factors in Chinese male survivors of myocardial infarction. Int J Cardiol. 1993;39:195-202.
6. Lehto S, Palomaki P, Miettinen H, et al. Serum cholesterol and high density lipoprotein cholesterol distributions in patients with acute myocardial infarction and in the general population of Kuopio province, eastern Finland. J Intern Med. 1993;233:179-185.
7. Nayak SB, Pinto Pereira LM, Boodoo S, et al. Association of troponin T and altered lipid Profile in patients admitted with acute myocardial infarction. Arch Physiol Biochem. 2010;116:21-27.
8. Gaziano JM, Hennekens CH, Satterfeld S, et al. Clinical utility of lipid and lipoprotein levels during hospitalization for acute myocardial infarction. Vasc Med. 1999;4:227-231.
9. Koro CE, Bowlin SJ, Stump TE, Sprecher DL, Tierney WM. The independent correlation between high density lipoprotein cholesterol and subsequent major adverse coronary events. Am Heart J. 2006;151:755. e1-e6.
10. Olsson AG, Schwartz GG, Szarek M, et al. High density lipoprotein, but not low density lipoprotein cholesterol levels infuence short term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J. 2005;26:890-896.
11. Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly. Chin Med J. 2004;117:511-515.
12. Alpert JS, Thygesen K, Antman E, Bassand JP Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
13. Braunwald E. Unstable angina: a classification. Circulation. 1989;80:410-414.
14. Gorecki A, Bednarz B, Jaxa Chamiec T, et al. Lipid Profile during the frst 24 hours after myocardial infarction has significant prognostic value. Kardiol Pol. 2004;60:229-236.
15. Akosah KO, Cerniglia RM, Havlik P, Schaper A. Myocardial infarction in young adults with low density lipoprotein cholesterol levels £ 100 mg/dL: clinical Profile and 1 year outcomes. Chest. 2001;120:1953-1958.
16. Pfohl M, Schreiber I, Liebich HM, Häring HU, Hoffmeister HM. Upregulation of cholesterol synthesis after acute myocardial infarction is cholesterol a positive acute phase reactant? Atherosclerosis. 1999;142:389-393.
17. Correia LC, Rocha MS, Esteves JP. HDL cholesterol level provides additional prognosis in acute coronary syndromes. Int J Cardiol. 2009;136: 307-314.
18. Rosoklija A, Georgievska Ismail L, Dzekova Stojkova S. Tracking the changes in the HDL cholesterol levels at different time intervals after acute myocardial infraction. Prilozi.2004;25:67-82.
19. Davidson MH, Toth PP. High density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol. 2007;100:n32-n40.
20. Al Aqeel A, Mojiminiyi OA, Al Dashti R, Al Ozairi ES. Differences in phy sician compliance with guideline on lipid Profile determination within 24h after acute myocardial infarction. Med Princ Pract.2005;14:41-45.
21. Theilmeier G, Schmidt C, Herrmann J, et al.High density lipoproteins and their constituent, sphingosine 1 phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation.2006;114:1403-1409.
22. Yokokawa H, Yasumura S, Tanno K, et al. Serum low density lipoprotein to high density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7 year cohort study of a Japanese northern rural population. J Atheroscler Thromb.2011;18:89-98.
23. Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK. Apo B/apo AI ratio: a better discriminator of coronary artery disease risk than other con ventional lipid ratios in Indian patients with acute myocardial infarction. Acta Cardiol.2008;63:749-755.
24. McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apo lipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case control study. Lancet. 2008;372: 224-233.
25. Blancke F, Claeys MJ, Jorens P, et al. Systemic Inflammation and reperfu sion injury in patients with acute myocardial infarction.Mediators Inflamm. 2005;2005:385-389.
26. Luo Y, Jiang D, Wen D, Yang J, Li L. Changes in serum interleukin 6 and high sensitivity Creactive protein levels in patients with acute coronary syndrome and their responses to simvastatin. Heart Vessels.2004;19: 257-262.
27. Auer J, Berent R, Lassnig E, Eber B. Creactive protein and coronary artery disease. Jpn Heart J.2002;43:607-619.
28. Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high sensitivity Creactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998.Clin Chem. 2008;54:335-342.
29. Suzuki M, Saito M, Nagai T, Saeki H, Kazatani Y.Systemic versus coronary levels of Inflammation in acute coronary syndromes. Angiology. 2006;57:459-463.
30. Ahmed K, Jeong MH, Chakraborty R, et al. Prognostic impact of baseline high sensitivity Creactive protein in patients with acute myocardial infarction undergoing percutaneous coronary intervention based on body mass index. Korean Circ J.2012;42:164-172.
31. Nozari Y, Geraiely B. Correlation between the serum levels of uric acid and HS CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction. Acta Med Iran.2011;49:531-535.
32. Yip HK, Wu CJ, Chang HW, et al. Levels and values of serum high sensitivity Creactive protein within 6 hours after the onset of acute myo cardial infarction. Chest.2004;126:1417-1422.
33. Li JJ, Jiang H, Huang CX, et al. Elevated level of plasma Creactive protein in patients with unstable angina: its relations with coronary stenosis and lipid Profile.Angiology.2002;53:265-272.